Hap Trading, LLC Cytokinetics Inc Call Options Transaction History

Hap Trading, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 12, 2024	BUY	$51.22 - $60.16 $2.05 Million - $2.41 Million	40,000 Added 38.99%	142,600 $381 Million
Q2 2024 Aug 14, 2024	SELL	$47.86 - $75.05 $37.6 Million - $59 Million	-786,400 Reduced 88.46%	102,600 $201 Million
Q1 2024 May 13, 2024	BUY	$63.75 - $108.06 $16 Million - $27.1 Million	250,800 Added 39.3%	889,000 $1.92 Billion
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $17.2 Million - $53.3 Million	638,200 New	638,200 $10.9 Billion
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $39,347 - $56,221	1,100 Added 8.46%	14,100 $308,000
Q3 2022 Nov 14, 2022	SELL	$38.54 - $54.52 $38,540 - $54,520	-1,000 Reduced 7.14%	13,000 $350,000
Q2 2022 Aug 12, 2022	BUY	$33.93 - $48.92 $33,930 - $48,920	1,000 Added 7.69%	14,000 $258,000
Q1 2022 May 12, 2022	BUY	$29.74 - $46.0 $386,620 - $598,000	13,000 New	13,000 $230,000
Q4 2019 Feb 11, 2020	SELL	$7.95 - $11.84 $795,000 - $1.18 Million	-100,000 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$10.82 - $14.25 $1.08 Million - $1.43 Million	100,000 New	100,000 $23,000

405

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.78B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.